Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-center observational study to assess addition of Rituximab in the treatment
of previously untreated patients with Diffuse Large B-Cell Lymphomas(DLBCL) over an
enrollment period of 60 months. Patients in this study are enrolling for the collection of
their data on observations made during normal clinical practice.